Tag: Kinnate Biopharma
Private equity firms who hold 45% of Kinnate Biopharma Inc. (NASDAQ:KNTE)...
Key InsightsThe considerable ownership by private equity firms in Kinnate Biopharma indicates that they collectively have a greater say in management and business strategyA...